Mini review article. Human herpesvirus-6 and the etiology of multiple sclerosis: a literature review

1. Enbom M, Wang F-Z, Fredrikson S, Martin C, Dahl H, Linde A. Similar humoral and cellular immunological reactivities to human herpesvirus 6 in patients with multiple sclerosis and controls. Clin Diagn Lab Immunol. 1999; 6:545-910.1128/CDLI.6.4.545-549.1999Search in Google Scholar

2. Mancuso R, Delbue S, Borghi E, Pagani E, Calvo MG, Caputo D, et al. Increased prevalence of varicella zoster virus DNA in cerebrospinal fluid from patients with multiple sclerosis. J Med Virol. 2007; 79:192-910.1002/jmv.20777Open DOISearch in Google Scholar

3. Challoner PB, Smith KT, Parker JD, Macleod DL, Coulter SN, Rose TN, et al. Plaque-associated expression of human herpesvirus 6 in multiple sclerosis. Proc Natl Acad Sci USA. 1995; 92:7440-4.10.1073/pnas.92.16.7440Open DOISearch in Google Scholar

4. Enbom M. Human herpesvirus 6 in the pathogenesis of multiple sclerosis. APMIS. 2001; 109:401-11.10.1034/j.1600-0463.2001.090601.xOpen DOISearch in Google Scholar

5. Stinissen P, Raus J, Zhang J. Autoimmune pathogenesis of multiple sclerosis: role of autoreactive T lymphocytes and new immunotherapeutic strategies. Crit Rev Immunol. 1997; 17:33-75.10.1615/CritRevImmunol.v17.i1.20Open DOISearch in Google Scholar

6. Hunter SF, Hafler DA. Ubiquitous pathogens. Links between infection and autoimmunity in MS? Neurology. 2000; 55:164-5.10.1212/WNL.55.2.164Open DOISearch in Google Scholar

7. Brown KA. Factors modifying the migration of lymphocytes across the blood-brain barrier. Int Immunopharmacol. 2001; 1:2043-62.10.1016/S1567-5769(01)00129-1Open DOISearch in Google Scholar

8. Bruck W. Clinical implications of neuropathological findings in multiple sclerosis. J Neurol. 2005; 252:III/ 10-4.10.1007/s00415-005-2011-516170494Search in Google Scholar

9. Harbige LS, Sharief MK. Polyunsaturated fatty acids in the pathogenesis and treatment of multiple sclerosis. Br J Nutr. 2007; 98:S46-53.10.1017/S000711450783301017922959Open DOISearch in Google Scholar

10. Gompels UA, Nicholas J, Lawrence G, Jones M, Thomson BJ, Martin MED, et al. The DNA sequence of human herpes virus-6 structure, coding content and genome evolution. Virology. 1995; 209:29-51.10.1006/viro.1995.12287747482Search in Google Scholar

11. Sanders VJ, Felisan S, Waddell A, Tourtellotte WW. Detection of herpesviridae in post-mortem multiple sclerosis brain tissue and controls by polymerase chain reaction. J Neurovirol. 1996; 2:249-58.10.3109/13550289609146888Open DOISearch in Google Scholar

12. Taus C, Pucci E, Cartechini E, Fie A, Guiliani G, Clementi M, et al. Absence of HHV-6 and HHV-7 in cerebrospinal fluid in relapsing-remitting multiple sclerosis. Acta Neurol Scand. 2000; 101:224-8.10.1034/j.1600-0404.2000.101004224.xOpen DOISearch in Google Scholar

13. Opsahl ML, Kennedy PGE. Early and late HHV-6 gene transcripts in multiple sclerosis lesions and normal appearing white matter. Brain. 2005; 128:516-27.10.1093/brain/awh390Search in Google Scholar

14. Matute C, Alberdi E, Domercq M, Perez-Cerda F, Perez-Samart☐n A, Sanchez-Gomez MV. The link between excitotoxic oligodendroglial death and demyelinating diseases. Trends Neurosci. 2001; 24: 224-30.10.1016/S0166-2236(00)01746-XOpen DOISearch in Google Scholar

15. Miller G. The dark side of glia. Science. 2005; 308: 778-81.10.1126/science.308.5723.77815879185Search in Google Scholar

16. Farooqui AA, Horrocks LA, Farooqui T. Modulation of inflammation in brain: a matter of fat. J Neurochem. 2007; 101:577-99.10.1111/j.1471-4159.2006.04371.x17257165Open DOISearch in Google Scholar

17. Clark DA. Human herpesvirus 6 and multiple sclerosis. Herpes. 1999; 6:73-7.Search in Google Scholar

18. Gopfert E, Pytlik S, Debuch H. 2′,3′-Cyclic nucleotide 3′-phosphohydrolase and lipids of myelin from multiple sclerosis and normal brains. J Neurochem. 1980; 34: 732-9.10.1111/j.1471-4159.1980.tb11205.x6243698Search in Google Scholar

19. Martin C, Enbom M, Soderstrom M, Fredrikson S, Dahl H, Lycke J, et al. Absence of seven human herpesviruses, Including HHV-6, by polymerase chain reaction in CSF and blood from patients with multiple sclerosis and optic neuritis. Acta Neurol Scand. 1997; 95:280-3. 10.1111/j.1600-0404.1997.tb00210.x9188902Open DOISearch in Google Scholar

20. Franciotta D, Bestetti A, Sala S, Perucca P, Jarius S, Price RW, et al. Broad screening for human herpesviridae DNA in multiple sclerosis cerebrospinal fluid and serum. Acta Neurol Belg. 2009; 109:277-82.Search in Google Scholar

21. Alvarez-Lafuente R, Garcia-Montojo M, De Las Heras V, Dominguez-Mozo MI, Bartolome M, Benito- Martin MS, et al. Herpesviruses and human endogenous retroviral sequences in the cerebrospinal fluid of multiple sclerosis patients. Mult Scler. 2008; 14:595-601.10.1177/135245850708642518566025Open DOISearch in Google Scholar

22. Mancuso R, Hernis A, Cavarretta R, Caputo D, Calabrese E, Nemni R, et al. Detection of viral DNA sequences in the cerebrospinal fluid of patients with Multiple Sclerosis. J Med Virol. 2009; 82:1051-7.10.1002/jmv.2176420419821Open DOISearch in Google Scholar

23. Sotelo J, Ordonez G, Pineda B, Flores J. The participation of varicella zoster virus in relapses of multiple sclerosis. Clin Neurol Neurosurg. 2014; 119: 44-8.10.1016/j.clineuro.2013.12.02024635924Open DOISearch in Google Scholar

24. van Nierop GP, Hintzen RQ, Verjans GMGM. Prevalence of human Herpesviridae in cerebrospinal fluid of patients with multiple sclerosis and noninfectious neurological disease in the Netherlands. J. Neurovirol. 2014; DOI 10.1007/s13365-014-0248-4.10.1007/s13365-014-0248-424671719Open DOISearch in Google Scholar

25. Mechelli R, Vittori D, Coarelli G, Aimati L, De Luca O, Romano S, et al. Screening for neurotropic viruses in cerebrospinal fluid of patients with multiple sclerosis and other neurological diseases. MSJ. 2014; 20:638.10.1177/135245851350123323959710Search in Google Scholar

26. Ahram M, El-Omar A, Baho Y, Lubad MA. Association between human herpesvirus 6 and occurrence of multiple sclerosis among Jordanian patients. Acta Neurol Scand. 2009; 120:430-5.10.1111/j.1600-0404.2009.01187.x19519805Open DOISearch in Google Scholar

27. Lublin FD, Reingold SC. Defining the clinical course of multiple sclerosis: Results of an international survey. Neurology. 1996; 46:907-11.10.1212/WNL.46.4.9078780061Open DOISearch in Google Scholar

28. Reipert B. Multiple sclerosis: a short review of the disease and its differences between men and women. J Men’s Health Gen. 2004; 1:334-40.10.1016/j.jmhg.2004.10.005Search in Google Scholar

29. Secchiero P, Zella D, Crowley RW, Gallo RC, Lusso P. Quantitative PCR for human herpesviruses 6 and 7. J Clin Microbiol. 1995; 33:2124-30.10.1128/jcm.33.8.2124-2130.19952283477559960Search in Google Scholar

30. Chapenko S, Millers A, Nora Z, Logina I, Kukaine R, Murovska M. Correlation between HHV-6 reactivation and multiple sclerosis disease activity. J Med Virol. 2003; 69:111-7.10.1002/jmv.1025812436486Search in Google Scholar

31. Alvarez-Lafuente R, Martin-Estefania C, de Las Heras V, Castrillo C, Picazo JJ, Varela de Seijas E, et al. Active human herpesvirus 6 infection in patients with multiple sclerosis. Arch Neurol. 2002; 59:929-33.10.1001/archneur.59.6.92912056928Search in Google Scholar

32. Behzad-Behbahani A, Hadi Mikaeili M, Entezam M, Mojiri A, Pour GY, Arasteh MM, et al. Human herpesvirus-6 viral load and antibody titer in serum samples of patients with multiple sclerosis. J Microbiol Immunol Infect. 2011; 44:247-51.10.1016/j.jmii.2010.08.00221524958Search in Google Scholar

33. Ohyashiki JH, Takaku T, Ojima T, Abe K, Yamamoto K, Zhang Y, et al. Transcriptional profiling of human herpesvirus type B (HHV-6B) in an adult T cell leukemia cell line as an in vitro model for persistent infection. Biochem Biophys Res Commun. 2005; 329:11-7.10.1016/j.bbrc.2005.01.090Search in Google Scholar

34. Adams CWM. Pathology of multiple sclerosis: progression of the lesion. Br Med Bull. 1977; 33:15-20.10.1093/oxfordjournals.bmb.a071388Search in Google Scholar

35. Hay KA, Tenser RB. Leukotropic herpesviruses in multiple sclerosis. Mult Scler. 2000; 6:66-8.10.1177/135245850000600202Open DOISearch in Google Scholar

36. Sotelo J, Ordonez G, Pineda B. Varicella-zoster virus at relapses of multiple sclerosis. J Neurol. 2007; 254: 493-500.10.1007/s00415-006-0402-xOpen DOISearch in Google Scholar

37. Hon GM, Erasmus RT, Matsha T. Low prevalence of human herpesvirus-6 and varicella zoster virus in blood of multiple sclerosis patients, irrespective of inflammatory status or disease progression. J Clin Neurosci. 2014; doi: 10.1016/j.jocn.2013.10.027. [Epub ahead of print]Search in Google Scholar

38. Fredj NB, Rotola A, Nefzi F, Chebel S, Rizzo R, Caselli E, et al. Identification of human herpesviruses 1 to 8 in Tunisian multiple sclerosis patients and healthy blood donors. J Neurovirol. 2006; 18:12-9.10.1007/s13365-011-0056-zSearch in Google Scholar

39. Mameli G, Astone V, Arru G, Marconi S, Lovato L, Serra C, et al. Brains and peripheral blood mononuclear cells of multiple sclerosis (MS) patients hyperexpress MS-associated retrovirus/HERV-W endogenous retrovirus, but not human herpesvirus 6. J Gen Virol. 2007; 88:264-74.10.1099/vir.0.81890-0Open DOISearch in Google Scholar

40. Alvarez-Lafuente R, Martin-Estefania C, de las Heras V, Castrillo C, Cour I, Picazo JJ, et al. Prevalence of herpesvirus DNA in MS patients and healthy blood donors. Acta Neurol Scand. 2002; 105:95-9.10.1034/j.1600-0404.2002.1o050.xOpen DOISearch in Google Scholar

41. Ablashi DV, Eastman HB, Owen CB, Roman MM, Friedman J, Zabriskie JB, et al. Frequent HHV-6 reactivation in multiple sclerosis (MS) and chronic fatigue syndrome (CFS) patients. J Clin Virol. 2000; 16: 179-91.10.1016/S1386-6532(99)00079-7Search in Google Scholar

42. Ben-Fredj N, Ben-Selma W, Rotola A, Nefzi F, Benedetti S, Frih-Ayed M, et al. Prevalence of human herpesvirus U94/REP antibodies and DNA in Tunisian multiple sclerosis patients. J Neurovirol. 2013; 19:42-7.10.1007/s13365-012-0138-623179681Search in Google Scholar

43. Alvarez-Lafuente R, de las Heras V, Bartolome M, Picazo JJ, Arroyo R. Relapsing-remitting multiple sclerosis and human herpesvirus 6 active infection. Arch Neurol. 2004; 61:1523-7.10.1001/archneur.61.10.1523Open DOISearch in Google Scholar

44. Schippling S, Heesen C, Zander A, Martin R. Stem cell transplantation in multiple sclerosis. J Neurol. 2008; 255:43-7.10.1007/s00415-008-6008-8Search in Google Scholar

45. Compston A, Coles A. Multiple sclerosis. Lancet. 2002; 359:1221-31.10.1016/S0140-6736(02)08220-XSearch in Google Scholar

46. Chatzimanolis N, Kraus J, Bauer R, Engelhardt B, Bregenzer T, Kuehne BS, et al. CD45RA + ICAM-3 + lymphocytes in interferon-β1b-treated and -untreated patients with relapsing-remitting multiple sclerosis. Acta Neurol Scand. 2004; 110:377-85.10.1111/j.1600-0404.2004.00346.x15527450Open DOISearch in Google Scholar

47. Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS), Neurology. 1983; 33:1444-52.10.1212/WNL.33.11.14446685237Open DOISearch in Google Scholar

48. Gustafsson R, Reitsma R, Stralfors A, Lindholm A, Press R, Fogdell-Hahn A. Incidence of human herpesvirus 6 in clinical samples from Swedish patients with demyelinating diseases. J Microbiol Immunol Infect. 2013; doi: 10.1016/j.jmii.2013.03.009. [Epub ahead of print] Search in Google Scholar